Inventor · disambiguated record
Dana Davis
Also filed as: DAVIS DANA · DAVIS DANA E
7 granted patents·4 pending applications·27 citations·filing 1999–2021
78Inventor score
Files withBIOELECTRON TECH CORP3EDISON PHARMACEUTICALS INC2PTC THERAPEUTICS INC2ARK THERAPEUTICS LTD1CONOPCO INC1
Top patents by PatentIndex Score
11 records- 0186US9296712B2Resorufin derivatives for treatment of oxidative stress disordersEDISON PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·12 cites·19 claims
- 0285US10470986B2Resorcinol compounds for dermatological useCONOPCO INC·Filed 2014·Granted Nov 12, 2019·10 cites·5 claims
- 0362US7223835B2VEGF peptides and their use for inhibiting angiogenesisARK THERAPEUTICS LTD·Filed 2001·Granted May 29, 2007·3 cites·9 claims
- 0460US2022257533A1Methods and compositions for treatment of inflammation and oxidative stressPTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0554US2020121618A1Methods and compositions for treatment of inflammation and oxidative stressBIOELECTRON TECH CORP·Filed 2018·Application pending·0 cites
- 0649US9868711B2Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disordersBIOELECTRON TECH CORP·Filed 2014·Granted Jan 16, 2018·0 cites·22 claims
- 0749US9670170B2Resorufin derivatives for treatment of oxidative stress disordersBIOELECTRON TECH CORP·Filed 2014·Granted Jun 6, 2017·0 cites·20 claims
- 0848US2023002324A1Naphthoquinone derivatives for treatment of oxidative stress disordersPTC THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0941US7371747B2Cyanoalkylamino derivatives as protease inhibitorsMERCK FROSST CANADA INC·Filed 2002·Granted May 13, 2008·0 cites·17 claims
- 1041US2014275045A1Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disordersEDISON PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1128US6569636B2Assay for modulators of metallo-enzyme activityHAWAII BIOTECH GROUP·Filed 1999·Granted May 27, 2003·2 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →